NEW YORK--(BUSINESS WIRE)--April 6, 2006--Xenomics, Inc. (OTCBB:XNOM - News; FWB:XE7), a developer of next-generation medical DNA technologies, has announced that Frederick Larcombe, Chief Financial Officer, will present an overview of the Company's breakthrough medical diagnostic technologies and innovative clinical programs at the upcoming BIO 2006 Annual International Convention conference, one of the biotechnology industry's leading annual forums.
